| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| Use of resources and cost implications of stroke prophylaxis with warfarinfor patients with nonvalvular atrial fibrillation |
Abdelhafiz, A.H.;Wheeldon, N.M.; |
The American Journal of Geriatric Pharmacotherapy |
2003-12-01 |
查看 |
| Anticoagulation influences long-term outcome in patients withnonvalvular atrial fibrillation and severe ischemic stroke |
Vemmos, K.N.;Tsivgoulis, G.;Spengos, K.;Manios, E.;Toumanidis, S.;Zakopoulos, N.;Moulopoulos, S.D.; |
The American Journal of Geriatric Pharmacotherapy |
2004-12-01 |
查看 |
| Cost-effectiveness of genotype-guided warfarin therapy foranticoagulation in elderly patients with atrial fibrillation |
Leey, J.A.;McCabe, S.;Koch, J.A.;Miles, T.P.; |
The American Journal of Geriatric Pharmacotherapy |
2009-08-01 |
查看 |
| Secondary Prevention of Stroke in the Elderly: A Review of the Evidence |
Alhusban, A.;Fagan, S.C.; |
The American Journal of Geriatric Pharmacotherapy |
2011-06-01 |
查看 |
| The Effect of Statins on Acute and Long-Term Outcome After IschemicStroke in the Elderly |
Hjalmarsson, C.;Bokemark, L.;Manhem, K.;Mehlig, K.;Andersson, B.; |
The American Journal of Geriatric Pharmacotherapy |
2012-10-01 |
查看 |
|
|
